Breaking News Instant updates and real-time market news.

TWTR

Twitter

$19.90

0.19 (0.96%)

, C

Citi

$74.05

-0.37 (-0.50%)

18:05
11/05/17
11/05
18:05
11/05/17
18:05

Prince Alwaleed arrest to reverberate across several companies, NY Times says

With the Prince Alwaleed bin Talal, Saudi Arabia has touched one of the richest and most influential investors in the world, with sizable stakes in Twitter (TWTR), Lyft and Citigroup (C), according to The New York Times. His arrest will likely reverberate across dozens of companies around the world that count the investment company that he founded, Kingdom Holding, as a major investor, the publication added. Reference Link

TWTR

Twitter

$19.90

0.19 (0.96%)

C

Citi

$74.05

-0.37 (-0.50%)

  • 08

    Nov

  • 16

    Nov

  • 07

    Dec

TWTR Twitter
$19.90

0.19 (0.96%)

11/03/17
11/03/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Buy from Hold at Argus with analyst Jim Kelleher citing an increase in user engagement, strong growth in adjusted EBITDA, and anticipated return to annual revenue growth next year. 2. Mattel (MAT) upgraded to Neutral from Underperform at DA Davidson with analyst Linda Bolton Weiser saying while the company suspended its dividend and saw a 51% decline in operating profit, she is positive on the company's 2-year $650M cost reduction program and plans to reduce its product range. 3. Wingstop (WING) upgraded to Buy from Hold at Stifel with analyst Chris O'Cull saying he thinks the consensus 2018 same-restaurant sales projection of 3% growth will prove conservative. 4. CACI (CACI) upgraded to Buy from Hold at Noble Financial with the firm's analyst saying the market overreacted to bookings and pipeline news, and views the pullback as a buying opportunity. 5. Regeneron (REGN) upgraded to Neutral from Underperform at Baird with analyst Brian Skorney citing better than expected Dupixent sales. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/03/17
ARGS
11/03/17
UPGRADE
Target $25
ARGS
Buy
Twitter upgraded to Buy at Argus on increasing user engagement
As previously noted, Argus analyst Jim Kelleher upgraded Twitter to Buy from Hold with a $25 price target, citing an increase in user engagement, strong growth in adjusted EBITDA, and anticipated return to annual revenue growth next year. Kelleher says that while Q3 revenue fell 4% on the year and ad revenue declined 8%, data & enterprise solutions sales were up over 20%. Usage also trended higher, with a 4% rise in monthly active users and a 14% increase in daily active users, says the analyst, adding that consensus estimates will move higher in Q4 and into FY18 based on the company's outlook for EBITDA margins.
11/03/17
ARGS
11/03/17
UPGRADE
ARGS
Buy
Twitter upgraded to Buy from Hold at Argus
10/27/17
10/27/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Amazon.com (AMZN) upgraded to Outperform from Market Perform at Raymond James with analyst Aaron Kessler saying he is incrementally more positive on robust and or accelerating growth across segments, accelerating international growth, gross margin expansion, AWS growth remained strong, and operating income that was at the high end of guidance. 2. Facebook (FB) upgraded to Buy from Neutral at Monness Crespi. 3. Twitter (TWTR) upgraded to Neutral from Sell at UBS with analyst Eric Sheridan saying he now views Twitter's risk/reward as more balanced. 4. IMAX (IMAX) upgraded to Overweight from Neutral at JPMorgan with analyst Alexia Quadrani saying she has more conviction that fundamentals will improve following the company's "strong" third quarter earnings report as management's "revenue-enhancing and cost-containment strategies beginning to materialize." 5. Intel (INTC) upgraded to Buy from Neutral at BofA/Merrill with analyst Vivek Arya saying new growth drivers in memory, mobile, AI, telco, IoT, programmable chips and autonomous cars will offset any PC weakness and weakness in PC/server markets. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
C Citi
$74.05

-0.37 (-0.50%)

10/16/17
10/16/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Citi (C) downgraded to Sell from Hold at Societe Generale with analyst Andrew Lim citing the bank's third quarter earnings report. 2. Deckers Brands (DECK) downgraded to Negative from Neutral at Susquehanna with analyst Sam Poser saying he believes its struggles will continue regardless of whether Marcato adds some of its people to the company's board. 3. Adobe (ADBE) downgraded to Hold from Buy at Deutsche Bank with analyst Nandan Amladi saying the valuation is "relatively full" with the shares up 50% year-to-date. 4. Ulta Beauty (ULTA) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Matthew Fassler saying recent data points, including a slowdown in Sephora U.S. sales and Bloomberg SpendTrend, suggest a more complicated path to recovery. 5. Bristol-Myers (BMY) downgraded to Hold from Buy at Jefferies with analyst Jeffrey Holford saying the shares, following the recent rally, have "significant downside risk" should lung cancer trial CheckMate-227 fail. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/16/17
SOCG
10/16/17
DOWNGRADE
Target $65
SOCG
Sell
Citi downgraded to Sell from Hold at Societe Generale
Societe Generale analyst Andrew Lim downgraded Citi to Sell and cut his price target for the shares to $65 from $70 following the bank's Q3 earnings report.
10/13/17
FBCO
10/13/17
NO CHANGE
Target $83
FBCO
Outperform
Citi decline on earnings due to soft credit card guidance, says Credit Suisse
Credit Suisse analyst Susan Katzke says yesterday's 3.4% slide in Citigroup stock price in spite of the earnings beat is likely due to its credit card guidance. Katzke says that even if Citi's North American card results fall 25% short of her forecast, it would result in a "manageable" 2% hit to EPS, maintaining her Outperform rating and $83 price target.
10/09/17
FBCO
10/09/17
NO CHANGE
Target $83
FBCO
Outperform
Citi price target raised to $83 from $73 at Credit Suisse
Credit Suisse analyst Susan Roth Katzke raised her price target for Citi to $83 from $73 on valuation. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

GPRO

GoPro

$6.30

0.01 (0.16%)

, JPM

JPMorgan

$114.46

0.13 (0.11%)

12:35
01/23/18
01/23
12:35
01/23/18
12:35
Hot Stocks
GoPro falls after Morgan Stanley downgrade cites limited strategic value »

Shares of GoPro (GPRO)…

GPRO

GoPro

$6.30

0.01 (0.16%)

JPM

JPMorgan

$114.46

0.13 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 07

    Feb

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

MET

MetLife

$53.56

-0.29 (-0.54%)

12:31
01/23/18
01/23
12:31
01/23/18
12:31
Hot Stocks
MetLife issues statement on court decision to dismiss appeal in SIFI litigation »

MetLife chairman,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 12

    Jun

CVE

Cenovus Energy

$10.43

0.04 (0.38%)

12:30
01/23/18
01/23
12:30
01/23/18
12:30
Options
Call buyers in Cenovus Energy as shares tick higher »

Call buyers in Cenovus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$135.52

0.31 (0.23%)

12:28
01/23/18
01/23
12:28
01/23/18
12:28
Technical Analysis
Technical Earnings Preview: United Technologies in uptrend before news »

The shares have been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

AGN

Allergan

$187.32

-0.83 (-0.44%)

12:25
01/23/18
01/23
12:25
01/23/18
12:25
Options
Allergan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 06

    Feb

  • 16

    Feb

  • 25

    Mar

12:25
01/23/18
01/23
12:25
01/23/18
12:25
Conference/Events
Leerink healthcare services analysts hold an analyst/industry conference call »

Healthcare Services…

VZ

Verizon

$53.23

-0.235 (-0.44%)

12:22
01/23/18
01/23
12:22
01/23/18
12:22
Periodicals
Verizon giving employees 50 shares of restricted stock, CNBC reports »

CNBC's David Faber…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

CHFN

Charter Financial

$18.13

-0.12 (-0.66%)

12:21
01/23/18
01/23
12:21
01/23/18
12:21
Hot Stocks
Charter Financial raises quarterly dividend to 8c per share from 5c »

Charter Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

21st Century Fox

$36.96

0.7 (1.93%)

, FOXA

21st Century Fox

$37.31

0.66 (1.80%)

12:20
01/23/18
01/23
12:20
01/23/18
12:20
Hot Stocks
21st Century Fox 'welcomes' part of CMA finding, 'disappointed' about plurality »

21st Century Fox (FOXA)…

FOX

21st Century Fox

$36.96

0.7 (1.93%)

FOXA

21st Century Fox

$37.31

0.66 (1.80%)

SKYAY

Sky

$55.97

0.72 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 07

    Feb

$NSD

NASDAQ Market Internals

12:17
01/23/18
01/23
12:17
01/23/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$227.58

7.12 (3.23%)

, AMZN

Amazon.com

$1,327.31

32.73 (2.53%)

12:16
01/23/18
01/23
12:16
01/23/18
12:16
Hot Stocks
Netflix's 'Mudbound' gets four Oscar noms, Amazon's 'The Big Sick' gets nod »

Films produced by Netflix…

NFLX

Netflix

$227.58

7.12 (3.23%)

AMZN

Amazon.com

$1,327.31

32.73 (2.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 01

    Feb

  • 18

    Mar

$NYE

NYSE Market Internals

12:16
01/23/18
01/23
12:16
01/23/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HPE

HP Enterprise

$16.46

0.41 (2.55%)

12:15
01/23/18
01/23
12:15
01/23/18
12:15
Options
Hewlett Packard Enterprise put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

NFLX

Netflix

$227.58

7.12 (3.23%)

, TRV

Travelers

$145.27

5.92 (4.25%)

12:10
01/23/18
01/23
12:10
01/23/18
12:10
General news
On The Fly: Top stock stories at midday »

Stocks opened little…

NFLX

Netflix

$227.58

7.12 (3.23%)

TRV

Travelers

$145.27

5.92 (4.25%)

VZ

Verizon

$53.31

-0.15 (-0.28%)

JNJ

Johnson & Johnson

$143.58

-4.565 (-3.08%)

PG

Procter & Gamble

$89.11

-2.78 (-3.03%)

TSLA

Tesla

$351.56

1.54 (0.44%)

RMD

ResMed

$103.82

16.306 (18.63%)

WHR

Whirlpool

$171.12

4.47 (2.68%)

TWTR

Twitter

$22.96

-0.36 (-1.54%)

INSM

Insmed

$30.86

1.58 (5.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 25

    Jan

  • 30

    Jan

  • 07

    Feb

  • 08

    Feb

  • 16

    Feb

  • 28

    Feb

  • 08

    Mar

UAL

United Continental

$76.96

0.09 (0.12%)

12:07
01/23/18
01/23
12:07
01/23/18
12:07
Technical Analysis
Technical Earnings Preview: United Continental has a potential bullish pattern »

Heading into earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 21

    Mar

RHHBY

Roche

$30.79

0.1 (0.33%)

12:05
01/23/18
01/23
12:05
01/23/18
12:05
Hot Stocks
Roche subsidiary treatment of gastric cancer granted FDA orphan status »

Genentech, a subsidiary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 23

    Feb

SQ

Square

$44.69

-0.6 (-1.32%)

12:05
01/23/18
01/23
12:05
01/23/18
12:05
Options
Square call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

ATVI

Activision Blizzard

$71.30

0.73 (1.03%)

12:04
01/23/18
01/23
12:04
01/23/18
12:04
Recommendations
Activision Blizzard analyst commentary  »

Cowen sees 'some…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

MDCO

The Medicines Co.

$28.81

3.98 (16.03%)

12:04
01/23/18
01/23
12:04
01/23/18
12:04
Hot Stocks
The Medicines Co. treatment of HoFH granted FDA orphan designation »

The FDA granted orphan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

TRNC

tronc

$21.00

1.47 (7.53%)

12:01
01/23/18
01/23
12:01
01/23/18
12:01
Periodicals
Tronc in talks for news partnership with Axios, WSJ says »

Los Angeles Times owner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

CREE

Cree

$36.69

0.4 (1.10%)

11:59
01/23/18
01/23
11:59
01/23/18
11:59
Technical Analysis
Technical Earnings Preview: Cree has a potential bearish pattern »

Ahead of earnings news,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ARNA

Arena Pharmaceuticals

$35.89

0.29 (0.81%)

11:58
01/23/18
01/23
11:58
01/23/18
11:58
Conference/Events
Arena Pharmaceuticals to hold Key Opinion Leader Event »

Key Opinion Leader…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$235.01

-9.12 (-3.74%)

11:57
01/23/18
01/23
11:57
01/23/18
11:57
Recommendations
Ulta Beauty analyst commentary  »

Ulta Beauty coupon likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCG

Scana

$43.80

0.44 (1.01%)

11:55
01/23/18
01/23
11:55
01/23/18
11:55
Options
SCANA put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
01/23/18
01/23
11:55
01/23/18
11:55
General news
Fed board nominee Goodfriend said the Fed was on the right path »

Fed board nominee…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.